Literature DB >> 10751318

Involvement of estrogen receptors alpha and beta in the regulation of cervical permeability.

G I Gorodeski1, D Pal.   

Abstract

Estrogen increases the permeability of cultured human cervical epithelia (Gorodeski, GI. Am J Physiol Cell Physiol 275: C888-C899, 1998), and the effect is blocked by the estrogen receptor modulators ICI-182780 and tamoxifen. The objective of the study was to determine involvement of estrogen receptor(s) in mediating the effects on permeability. In cultured human cervical epithelial cells estradiol binds to high-affinity, low-capacity sites, in a specific and saturable manner. Scatchard analysis revealed a single class of binding sites with a dissociation constant of 1.3 nM and binding activity of approximately 0.5 pmol/mg DNA. Estradiol increased the density of estrogen-binding sites in a time- and dose-related manner (half time approximately 4 h, and EC(50) approximately 1 nM). RT-PCR assays revealed the expression of mRNA for the estrogen receptor alpha (alphaER) and estrogen receptor beta (betaER). Removal of estrogen from the culture medium decreased and treatment with estrogen increased the expression of alphaER and betaER mRNA. In cells not treated with estrogen, ICI-182780 and tamoxifen increased betaER mRNA. In cells treated with estrogen, neither ICI-182780 nor tamoxifen had modulated significantly the increase in alphaER or betaER mRNA. The transcription inhibitor actinomycin D blocked the estrogen-induced increase in permeability, and it abrogated the estradiol-induced increase in estrogen binding sites. These results suggest that the estrogen-dependent increase in cervical permeability is mediated by an alphaER-dependent increase in transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751318     DOI: 10.1152/ajpcell.2000.278.4.C689

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

1.  Estrogen regulates epithelial cell deformability by modulation of cortical actomyosin through phosphorylation of nonmuscle myosin heavy-chain II-B filaments.

Authors:  Xin Li; Lingying Zhou; George I Gorodeski
Journal:  Endocrinology       Date:  2006-08-10       Impact factor: 4.736

Review 2.  Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes.

Authors:  Hyunyoung Jeong
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-06       Impact factor: 4.481

3.  Effects of estrogen on proton secretion via the apical membrane in vaginal-ectocervical epithelial cells of postmenopausal women.

Authors:  George I Gorodeski
Journal:  Menopause       Date:  2005-11-08       Impact factor: 2.953

4.  Estrogen modulation of MgATPase activity of nonmuscle myosin-II-B filaments.

Authors:  George I Gorodeski
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

5.  Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells.

Authors:  George I Gorodeski; Ulrich Hopfer; Chung Chiun Liu; Ellen Margles
Journal:  Endocrinology       Date:  2004-10-21       Impact factor: 4.736

6.  Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms.

Authors:  Ling Zhu; Xin Li; Robin Zeng; George I Gorodeski
Journal:  Endocrinology       Date:  2005-10-20       Impact factor: 4.736

7.  Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women.

Authors:  George I Gorodeski
Journal:  Menopause       Date:  2007 Nov-Dec       Impact factor: 2.953

8.  The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules.

Authors:  Cleida A Oliveira; Rong Nie; Kay Carnes; Luiz R Franca; Gail S Prins; Philippa T K Saunders; Rex A Hess
Journal:  Reprod Biol Endocrinol       Date:  2003-10-10       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.